At B&B Life Science, we develop an extensive and synergistic range of generic and specialty medicines addressing a broad spectrum of chronic and acute treatments. Our diverse product portfolio spans generics, branded generics, specialty, technology-intensive products, over-the-counter (OTC) items, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs), and intermediates. Operating in over 100 countries, we prioritize responsiveness to local treatment requirements while consistently enhancing our global product lineup.